Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
1.380
+0.010 (0.73%)
At close: Jan 27, 2026, 4:00 PM EST
1.380
0.00 (0.01%)
After-hours: Jan 27, 2026, 7:56 PM EST

Geron Revenue

Geron had revenue of $47.23M in the quarter ending September 30, 2025, with 67.05% growth. This brings the company's revenue in the last twelve months to $183.40M, up 522.13% year-over-year. In the year 2024, Geron had annual revenue of $76.99M with 32,386.92% growth.

Revenue (ttm)
$183.40M
Revenue Growth
+522.13%
P/S Ratio
5.01
Revenue / Employee
$800,886
Employees
229
Market Cap
880.93M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202476.99M76.76M32,386.92%
Dec 31, 2023237.00K-359.00K-60.23%
Dec 31, 2022596.00K-797.00K-57.21%
Dec 31, 20211.39M1.14M450.59%
Dec 31, 2020253.00K-207.00K-45.00%
Dec 31, 2019460.00K-606.00K-56.85%
Dec 31, 20181.07M1,000.000.09%
Dec 31, 20171.07M-5.10M-82.72%
Dec 31, 20166.16M-30.21M-83.06%
Dec 31, 201536.37M35.22M3,054.47%
Dec 31, 20141.15M-130.00K-10.13%
Dec 31, 20131.28M-1.43M-52.64%
Dec 31, 20122.71M271.00K11.12%
Dec 31, 20112.44M-1.13M-31.57%
Dec 31, 20103.56M1.84M106.43%
Dec 31, 20091.73M-1.08M-38.42%
Dec 31, 20082.80M-4.82M-63.22%
Dec 31, 20077.62M4.35M132.59%
Dec 31, 20063.28M-2.88M-46.78%
Dec 31, 20056.16M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Arvinas312.30M
Valneva SE211.09M
Maravai LifeSciences Holdings192.44M
Xencor150.13M
CytomX Therapeutics113.63M
UroGen Pharma96.52M
Janux Therapeutics10.00M
YD Bio510.36K
Revenue Rankings